Across TCGA pan-cancer cohorts, RPS29P9 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS29P9’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPS29P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS29P9 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

LUAD, HNSC, and KIRP are the cancer types where RPS29P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS29P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.128	.001	4	view →
HNSC	All	II,III,IV	+0.086	.018	4	view →
KIRP	Male	All	+0.082	.043	2	view →
KIRC	Male	III,IV	−0.046	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPS29P9 RNA expression & survival · all RPS29P9 data types